77 unselected adult patients with acute myeloblastic leukaemia ( aml ) , including practically all aml patients from an area with 1.9 million inhabitants , were randomized for either ( 1 ) 5 days pretreatment with 1-asparaginase and prednisolone followed by a combination of rubidomycin and cytosine arabinoside ( arap ) , or ( 2 ) treatment with a combination of rubidomycin , cytosine arabinoside and prednisolone without 1-asparaginase pretreatment ( rap ) .
C0023467
aml
C0011015
rubidomycin